Lotus Lake Ventures

Lotus Lake Ventures is an investment firm dedicated to supporting science and technology innovation enterprises, focusing on high-tech companies with core competencies in the initial and growth stages. As a venture capital arm of Tus-Holdings Co., Ltd., Lotus Lake Ventures specializes in start-up, early stage, and growth capital investments primarily in the information technology, life sciences, and clean technology sectors. Additionally, the firm also invests in modern services, advanced manufacturing, new materials, creative, technology, media, telecommunications, cultural media, and biotechnology sectors. Founded in 2001 and headquartered in Beijing, China, Lotus Lake Ventures has an additional office in Hangzhou, China, solidifying its commitment to fostering innovation and technological advancement in the business landscape.

Zhou Han

Managing Director

Tao Jiang

Investment Director

Guo Kai

Managing Director

Guangchao Li

Managing Director

Huiqin Liu

Managing Director

Tao Zhang

VP, Investments

Shanliang Zhang

Managing Director

Fuqiang Zhao

Investment Director

64 past transactions

Slichem

Series A in 2021
Slichem develops liquid crystal materials and fine chemicals. They manufacture display materials. Their products include liquid crystal materials for display and OLED materials.

Insight Lifetech

Series B in 2020
Insight Lifetech Co., Ltd. (Shenzhen) is headquartered in China.

Yaohai Biopharm

Private Placement in 2020
Yaohai Biopharm develops genetically engineered protein drugs. The company was founded in 2010 and is based in Taizhou, China.

TUS International

Private Placement in 2019
TUS International is driving the core smart and connected vehicle technologies in China’s national strategy of “Made in China 2025”. They strive to become an intelligent driving and solution provider and lead the eco-system of constructing smart and connected automobiles. TUS International is set out to lead the development of China’s smart vehicle system and explores overseas (especially the United States and Europe) investment opportunities in the automobile industry.

Sumavision

Series A in 2001
Beijing Sumavision Co., Ltd. is a Chinese high-tech company that provides digital TV software and systems. Sumavision is the only company that can provide digital TV complete system solutions and one-stop service. Its front-end hardware products took first place in the domestic market share for seven successive years, and also took 50% of the market share in national digital TV translation provinces. The products of Sumavision are used in 43 provinces and regions in China, and over 40 national and provincial broadcast and TV arterial grid or centering systems, as well as over 700 TV city and county stations. Its market share takes the lead among similar Chinese products. In the overseas market, Sumavision's products have been imported to over 70 countries and regions. At present, the volume of trade in Europe and North America takes one third of the whole volume of overseas trade. As of March 2000, Sumavision has a registered capital of 112 million RMB. In 2010, Sumavision successfully got listed on China's Growth Enterprise Market. Currently, Sumavision has a market value of about 7 billion. It is also financed by Beijing Gehua Cable TV Network, Hunan TV & Broadcast Intermediary, and TusPark.

ACCB Biotech

Series A in 2005
Beijing ACCB Biotech Ltd. (雅康博生物) is focused on the research and development of cancer detection methods through the application of molecular biology technologies. Based on the concept of personalized therapy, the company provides detection services that include early-cancer screening, drug selection, effect tracking, prognostic evaluation, transfer and recurrence monitoring, and other testing services. ACCB Biotech’s product series include EnzymAct, Baikangan, Gene 21 of Breast Cancer, automated workstation for nucleic acid extraction, and more. The company now has production, research and development, and service facilities of more than 3,000 square meters, and its cleanliness attains the criteria of 10,000 grades. In June, 2009, EnzymAct® was successfully approved by the State Food and Drug Administration.

Palmap

Series B in 2013
Palmap Intelligence Co., Ltd develops a mobile application for indoor map and location services. The company provides indoor maps which help users locate indoor shops, cinemas, and public facilities in malls. Palmap Intelligence Co., Ltd was founded in 2012 and is headquartered in Shanghai, China. Palmap Intelligence Co., Ltd operates as a subsidiary of Budong Information Holding Stock Company.

Beijing Lidakang Technology

Private Placement in 2019
Beijing Lidakang Technology Co., Ltd. manufactures and sells surgical implants. It offers hip joint system of microporous titanium alloy, the stable knee joint system with high flexion, and the joint bone tumor joint system. The company was founded in 1998 and is based in Beijing, China.

Kanova

Series A in 2018
Kanova is a biopharmaceutical firm.

UNIFLY

Angel Round in 2007
Beijing Unifly Scientific and Technology Company Limited researches, develops, manufactures, and sells filters, low-carbon lubricants, glass cleaners, antifreeze coolants, and other car maintenance products. The company offers car filters, industrial filters, and lube oil products. It serves transportation, automobile parts, mining, metallurgy, power generation, and other industries. Beijing Unifly Scientific and Technology Company Limited was founded in 1995 and is based in Beijing, China with a research and development center in Langfang, China.

Shenogen Pharma Group

Series A in 2011
Shenogen Pharma Group is a drug discovery and development company.
Shenzhen Huada Beidou Technology Company Limited is engaged in independent design, research, development, sales and related business of navigation positioning chips, algorithms and products. The firm was founded in 2016 and is headquartered in Shenzhen, China.

UNIFLY

Post in 2010
Beijing Unifly Scientific and Technology Company Limited researches, develops, manufactures, and sells filters, low-carbon lubricants, glass cleaners, antifreeze coolants, and other car maintenance products. The company offers car filters, industrial filters, and lube oil products. It serves transportation, automobile parts, mining, metallurgy, power generation, and other industries. Beijing Unifly Scientific and Technology Company Limited was founded in 1995 and is based in Beijing, China with a research and development center in Langfang, China.

Hanyu Medical

Series B in 2018
Shanghai Hanyu Medical Technology Co., Ltd. engages in the research and development of medical devices in the field of heart valve diseases. The company's product ValveClamp is a mitral valve intervention device which is used for minimally invasive interventional treatment of mitral valve regurgitation diseases. The company was incorporated in 2016 and is based in Shanghai, China with additional office in Beijing, China.

Beijing VDJBio Co., LTD.

Private Placement in 2020
Beijing VDJBio Co., LTD. offers research and development of monoclonal antibody drugs. The company researches the maturation mechanism of human antibodies to develop antibody drugs and antibody fusion protein drugs. Beijing VDJBio Co., LTD. was founded in 2011 and is based in Beijing, China.

Sinotau

Private Placement in 2020
Beijing Sinotau Intl. Pharmaceutical Technology Co., Ltd. operates as an integrated pharmaceutical group that offers generic and patented therapies and diagnostic agents. The company provides radiopharmaceutical and bio-pharmaceuticals products. It manufactures antibiotics, vitamins, hormone, oncology, digestive system, cardiovascular system, diabetes, respiratory system, and gynecology tablets, capsules, and granules. The company was founded in 2005 and is based in Beijing, China with an additional office in Haikou, China.

SolarVista Media

Series D in 2013
SolarVista Media provides DCP billboards that run on natural light to change images electronically with no plastic waste when campaigns change.
Beijing Lidakang Technology Co., Ltd. manufactures and sells surgical implants. It offers hip joint system of microporous titanium alloy, the stable knee joint system with high flexion, and the joint bone tumor joint system. The company was founded in 1998 and is based in Beijing, China.

OptoMedic

Private Placement in 2020
Guangzhou OptoMedic Co., Ltd. engages in research, development, and manufacture of optical medical device and systems. It offers intraoperative endoscopic fluorescence navigation system for general surgery departments. The company was founded in 2013 and is based in Foshan, China.

Kanova

Series B in 2021
Kanova is a biopharmaceutical firm.

Laviana Pharma

Series A in 2014
Laviana Pharma Co., Ltd. founded in 2005 is a high-tech enterprise. It specializes in providing process and manufacture outsourcing services (CDMO) for the pharmaceutical industry. The main scope of services covers all chemistry-related aspects of process development and transformation for the innovative drug substances and products from laboratory scale to commercialized scale, including process research, process development, process optimization, pilot production and large-scale production of intermediates, API starting materials and API (active pharmaceutical ingredient) for pre-clinical, clinical trial materials and commercialized products. It also provides CMC services for IND and NDA submission of innovative developmental drug. It has three wholly-owned subsidiary, namely, Beijing laviana Pharmatech Co., Ltd., Laviana (Tianjin) Pharmatech Development Co., Ltd., and Laviana Corporation incorporated in United States.

Sumavision

Series D in 2006
Beijing Sumavision Co., Ltd. is a Chinese high-tech company that provides digital TV software and systems. Sumavision is the only company that can provide digital TV complete system solutions and one-stop service. Its front-end hardware products took first place in the domestic market share for seven successive years, and also took 50% of the market share in national digital TV translation provinces. The products of Sumavision are used in 43 provinces and regions in China, and over 40 national and provincial broadcast and TV arterial grid or centering systems, as well as over 700 TV city and county stations. Its market share takes the lead among similar Chinese products. In the overseas market, Sumavision's products have been imported to over 70 countries and regions. At present, the volume of trade in Europe and North America takes one third of the whole volume of overseas trade. As of March 2000, Sumavision has a registered capital of 112 million RMB. In 2010, Sumavision successfully got listed on China's Growth Enterprise Market. Currently, Sumavision has a market value of about 7 billion. It is also financed by Beijing Gehua Cable TV Network, Hunan TV & Broadcast Intermediary, and TusPark.

NeuralGalaxy

Series A in 2021
Neural Galaxy is a brain science company that originated at Harvard Medical School and the Massachusetts Institute of Technology. The mission of Younao Galaxy is to help solve brain diseases and achieve greater intelligence. Focusing on global vision, based on breakthrough brain science research results, using new software and hardware technologies, Younao Galaxy helps humans to deeply understand our brains, understand high-level intelligence, and solve the enormous challenges facing human society.

China Immunotech

Series B in 2022
China Immunotech is a small molecule innovative drug R&D company developing immune cell therapy technologies and products. Including CAR-T and TCR-T cell therapy with independent intellectual property rights. It was founded in March 2018 by famous immunologists.

Hongyun Biology

Series B in 2023
Hongyun Biotech is a biotech company that promotes therapeutic innovation based on structural pharmacology.

Global Gem Exchange

Angel Round in 2011
Operator of a diamond exchange intended to facilitate the trading of diamonds and gems in the global market. The company aims to directly connect global diamond suppliers with diamond retailers, enabling clients to increase their gem stock and generate more revenue.

Hisign Technology

Series C in 2012
Beijing Hisign Technology Co., Ltd. (Hisign), established in 1998, is a high-growth enterprise group including wholly owned, controlled and shareholding subsidiaries. It is ISO 9001, ISO/IEC20000-1 and ISO/IEC27001 certified. It is a national high-tech enterprise of China. Beijing Hisign Technology Co., Ltd. is widely regarded as the most comprehensive and perfect enterprise in Chinese multi-biometrics industry, with state-of-art techniques of face recognition, fingerprint identification, palm print matching, handwriting and vehicle license plate recognition etc. Its products and businesses cover four fields: multi-biometrics recognition, video image processing and analysis, the comprehensive application of criminal investigation information, as well as financial risk prevention and control with big data analysis. The products are widely used in public security fields such as criminal investigation, security, forensics, border control, and also in civil fields such as finance, social security, education, transportation, large-scale event management, surveillance and internet application.

Shenzhen Xinnuo Health Industry Investment Co., Ltd.

Merger/Acquisition in 2016
Shenzhen Xinnuo Health Industry Investment Co., Ltd. is headquartered in China.

Chezhency.com

Private Placement in 2018
Chezhency.com operates as a B2B auto trading platform, which integrates automotive logistics, supply chain finance, consumer credit, automobile insurance and other services. The company was founded in 2015 and is based in Shenzhen, China.

Chinagene Tech

Seed Round in 2021
Beijing Zhongyin Technology Co., Ltd. is a professional enterprise engaged in the research and development of clinical genetic diagnosis, prevention and gene therapy for hereditary eye diseases. The company's clinical genetic diagnosis platform for hereditary eye diseases can provide fast, accurate, reliable and professional clinical genetic diagnosis services for hereditary ophthalmology patients.

Hanyu Medical

Private Placement in 2018
Shanghai Hanyu Medical Technology Co., Ltd. engages in the research and development of medical devices in the field of heart valve diseases. The company's product ValveClamp is a mitral valve intervention device which is used for minimally invasive interventional treatment of mitral valve regurgitation diseases. The company was incorporated in 2016 and is based in Shanghai, China with additional office in Beijing, China.

Shenzhen Hexin Medical Technology Co., Ltd.

Private Placement in 2019
Shenzhen Hexin Medical Technology Co., Ltd. engages in the research and development of active implantable medical devices. The company was founded in 2016 and is based in China.

Immupeutics Medicine

Seed Round in 2021
Immupeutics Medical Technology Co., Ltd. is a biomedical research technology company dedicated to the development and application of tumor immunotherapy technology. The company mainly involves the research and application of immunotherapy for many different types of tumors.

SINOGENE

Series A in 2018
Beijing Sinogene Biotechnology Co., Ltd. is engaged in commercial pet cloning and gene editing technology services. The firm was founded in 2012 and is headquartered in Beijing, China.

Sensylink

Series B in 2019
Sensylink Microelectronics Co, Ltd., designs, develops, manufactures and markets environmental sensor ICs, including Temperature sensor IC, Humidity sensor IC and Gas sensor IC. Sensylink’s products combine the innovative sensor technology and IC process/design technology together. As a result, Sensylink’s products are highly integrated, high precision, miniature size, low power consumption and low cost. Sensylink’s mission is to be based in China and to provide worldwide customers with the most cost-effective environmental sensor components and services.

Sightnovo

Private Placement in 2020
Sightnovo Medical Technology Co., Ltd offers diagnostic solutions in ophthalmology. The company develops detection devices, consumable, and reagents. Sightnovo Medical Technology Co., Ltd was founded in 2018 and is based in Haidian, China.

Kanova

Private Placement in 2018
Kanova operates as a biopharmaceutical company that develops antibody drugs for the immune system. The company is based in China.

AISpeech

Series A in 2012
AISpeech is a high-tech start up specialized in computer speech recognition, analysis, tone analysis and dialog management techniques.

Intengine Technology

Series A in 2018
Beijing based Robotics company.

OptoMedic

Series C in 2020
Guangzhou OptoMedic Co., Ltd. engages in research, development, and manufacture of optical medical device and systems. It offers intraoperative endoscopic fluorescence navigation system for general surgery departments. The company was founded in 2013 and is based in Foshan, China.

Intengine Technology

Private Placement in 2018
Intengine Technology designs and develops artificial intelligence (AI) and robotics solutions. Its solutions include security monitoring; provides AI cores for terminal equipment and neural networks to upgrade the security monitoring system, autopilot; which provides miniaturized chips to help achieve L3, L4 automatic driving, human-computer interaction; it offers solutions to a variety of devices and platforms and provides ways to interact with devices, and industrial wisdom; it offers industrial manufacturing solutions that can process input data, such as images, video, and cloud points and increase the level of miniaturization of industrial robots. The company is based in company based in Beijing, China.

ChineseAll Digital Publishing

Venture Round in 2010
Chinese Online (中文在线) is a company focused on digital publishing. It provides digital reading products to mobile phones, hand-held terminals, and the internet as well as other media. Chinese Online takes copyright organizations and authors as the genuine digital content source, and collaborates with them to manage the content. It also offers value-added services of digital content such as copyright derivatives and more. As a leading enterprise of digital publishing domestically, Chinese Online has established a complete media publishing model of unique content, variety in media and synchronized publishing.

Chinagene Tech

Seed Round in 2021
Beijing Zhongyin Technology Co., Ltd. is a professional enterprise engaged in the research and development of clinical genetic diagnosis, prevention and gene therapy for hereditary eye diseases. The company's clinical genetic diagnosis platform for hereditary eye diseases can provide fast, accurate, reliable and professional clinical genetic diagnosis services for hereditary ophthalmology patients.

Kanova

Series B in 2023
Kanova is a biopharmaceutical firm.

Sinotau

Series C in 2020
Beijing Sinotau Intl. Pharmaceutical Technology Co., Ltd. operates as an integrated pharmaceutical group that offers generic and patented therapies and diagnostic agents. The company provides radiopharmaceutical and bio-pharmaceuticals products. It manufactures antibiotics, vitamins, hormone, oncology, digestive system, cardiovascular system, diabetes, respiratory system, and gynecology tablets, capsules, and granules. The company was founded in 2005 and is based in Beijing, China with an additional office in Haikou, China.

Sinotau

Series E in 2023
Beijing Sinotau Intl. Pharmaceutical Technology Co., Ltd. operates as an integrated pharmaceutical group that offers generic and patented therapies and diagnostic agents. The company provides radiopharmaceutical and bio-pharmaceuticals products. It manufactures antibiotics, vitamins, hormone, oncology, digestive system, cardiovascular system, diabetes, respiratory system, and gynecology tablets, capsules, and granules. The company was founded in 2005 and is based in Beijing, China with an additional office in Haikou, China.

Cygnus Biosciences

Series C in 2023
Cygnus Biosciences (Beijing) Co., Ltd engages in gene sequencing. Its products include sequencing devices, supporting chips, and reagents for disease diagnosis and screening. The company was founded in 2015 and is based in Beijing, China.

Sensylink

Private Placement in 2019
Sensylink Microelectronics Co, Ltd., designs, develops, manufactures and markets environmental sensor ICs, including Temperature sensor IC, Humidity sensor IC and Gas sensor IC. Sensylink’s products combine the innovative sensor technology and IC process/design technology together. As a result, Sensylink’s products are highly integrated, high precision, miniature size, low power consumption and low cost. Sensylink’s mission is to be based in China and to provide worldwide customers with the most cost-effective environmental sensor components and services.

Suzhou Ribo Life Science

Series B in 2017
Suzhou Ribo Life Science is a developer of RNA interference ( RNAi ) technology designed to treat liver diseases. The company's RNA interference ( RNAi ) technology is used to develop nucleic acid therapeutic drugs and related products, enabling healthcare providers to deliver more effective pharmaceuticals to patients.